Omecamtiv Mecarbil: Phase 2 Study Shows No Improvement in Dyspnea AHF But Trend for Further Exploration

Article Information

DOI 
http://dx.doi.org/10.1177/155989771315011
Published By 
SAGE Publications
Print ISSN 
1559-8977
Online ISSN 
2155-756X
Copyright & Usage 
© 2013 MD Conference Express®

Author Information

  1. Toni Rizzo
  1. John R. Teerlink, MD
    1. University of California at San Francisco, San Francisco, California, USA
View Full Text

Article usage

AbstractFullPDF
Apr 2015500
May 2015100
Jul 2015100
Aug 2015300
Sep 2015200
Oct 2015132
Nov 2015111
Total1443

Note: Article usage statistics are calculated and reported monthly.

Cited By...

  • No citing articles found.
Back to top

Tools

View Full Page PDF
Citation Tools
Email
Omecamtiv Mecarbil: Phase 2 Study Shows No Improvement in Dyspnea AHF But Trend for Further Exploration
Permalink: Copy
Linkedin Share Button del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo StumbleUpon logo

Table of contents

Cited By...

  • No citing articles found.

Keywords

Cardiology Clinical Trials
Heart Failure
Cardiology Clinical Trials
Heart Failure
Cardiology